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Abstract
Background: Advances in nanotechnology have identified promising candidates for many biological, biomedical
and biomedicine applications. They are being increasingly exploited for medical uses and other industrial
applications. The aim of the present study was to investigate the effects of administration of gold nanoparticles
(GNPs) on inflammatory cells infiltration, central vein intima disruption, fatty change, and Kupffer cells hyperplasia
in the hepatic tissue in an attempt to cover and understand the toxicity and the potential threat of their
therapeutic and diagnostic use.
Methods: A total of 70 healthy male Wistar-Kyoto rats were exposed to GNPs received 50 or 100 μl of GNPs
infusion of 10, 20 and 50 nm GNPs for 3 or 7 days. Animals were randomly divided into groups, 12 GNPs-treated
rats groups and one control group (NG). Groups 1, 2 and 3 received infusion of 50 μl GNPs of size 10 nm (3 or 7
days), size 20 nm (3 or 7 days) and 50 nm (3 or 7 days), respectively; while groups 4, 5 and 6 received infusion of
100 μl GNPs of size 10 nm, size 20 nm and 50 nm, respectively.
Results: In comparison with respective control rats, exposure to GNPs doses has produced alterations in the
hepatocytes, portal triads and sinusoids. The alterations in the hepatocytes were mainly vacuolar to hydropic
degeneration, cytopasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis
and necrosis. In addition, inflammatory cell infiltration, Kupffer cells hyperplasia, central veins intima disruption,
hepatic strands dilatation and occasional fatty change together with a loss of normal architechiture of hepatic
strands were also seen.
Conclusions: The alterations induced by the administration of GNPs were size-dependent with smaller ones
induced more affects and related with time exposure of GNPs. These alterations might be an indication of injured
hepatocytes due to GNPs toxicity that became unable to deal with the accumulated residues resulting from
metabolic and structural disturbances caused by these NPs. These histological alterations may suggest that GNPs
interact with proteins and enzymes of the hepatic tissue interfering with the antioxidant defense mechanism and
leading to reactive oxygen species (ROS) generation which in turn may induce stress in the hepatocytes to
undergo necrosis.
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In vivo studies in rats exposed to aerosols of GNPs
revealed that the NPs were rapidly taken into the system
with the highest accumulation in the lungs, aorta, eso-
phagus and olfactory bulb [1]. Moreover, particles of
nano-dimension are believed to be more biologically
reactive than their bulk counter parts due to their small
size and larger surface area to volume ratio [1,2].
Gold in its bulk form has long been considered an
inert, noble metal with some therapeutic and even med-
icinal value hence GNPs are thought also to be relatively
non-cytotoxic [3]. Yet there are differing reports of the
extent of the toxic nature of these particles owing to the
different modifications of the GNPs, surface functional
attachments and shape and diameter size of the nano-
spheres [4,5]. Moreover, the metallic nature of the metal
derived NPs and the presence of transition metals
encourages the production of reactive oxygen species
(ROS) leading to oxidative stress [6,7].
Although some scientists consider NPs as nontoxic
[8-10], other cellular mechanisms such as cell signaling
and other normal cellular functions may be disrupted
and are currently undergoing further investigation
[11,12]. The toxicity of NPs is being addressed by a num-
ber of standardized approaches with in vitro, in vivo as
well as detailed genomic or biodistribution studies [12].
It has been shown that NPs may produce in vitro toxi-
city in some cell-based assays, but not in others. This
m a yb ear e s u l to fi n t e r f e r e n c ew i t ht h ec h e m i c a l
probes, differences in the innate response of particular
cell types, or other factors [13]. In addition, GNPs are
used as carriers for the delivery of drugs and genes [14].
GNPs can easily enter cells and the demonstration
that amine and thiol groups bind strongly to GNP has
enabled their surface modification with amino acids and
proteins for biomedical applications [15,16].
The histological and histochemical characterization in
the hepatic tissues due to GNPs has not been documen-
ted and identified. In the present study, an attempt has
been made to characterize the possible histological
alterations in the hepatic tissues after the administration
of GNPs and, if so, whether are related to the size of
these GNPs and the time of exposure.
The present study was carried out to investigate parti-
cle-size and administration period effects of GNPs on
inflammatory, central vein intima, fatty and Kupffer cells
hyperplasia disruption in an attempt to cover and
understand the toxicity and potential threat of their
therapeutic and diagnostic use.
Materials and methods
A total of 70 healthy male Wistar-Kyoto rats obtained
from the Laboratory Animal Center (College of Phar-
macy, King Saud University, Saudi Arabia). The rats
nearly of the same age (12 weeks old) and weighing
220-240 g of King Saud University colony were used.
Animals were randomly divided into groups, 12
GNPs-treated rats groups and one control group
(NG). Following a period of stabilization (7 days), 10,
20 and 50 nm GNPs were administered intraperito-
nealy at the rate for 3 or 7 days as follows: Group 1:
received infusion of 50 μlG N P so fs i z e1 0n mf o r3
or 7 days (n = 10); Group 2: received infusion of 50
μlG N P so fs i z e2 0n mf o r3o r7d a y s( n=1 0 ) ;
Group 3: received infusion of 50 μlG N P so fs i z e5 0
nm for 3 or 7 days (n = 10); Group 4: received infu-
sion of 100 μlG N P so fs i z e1 0n mf o r3o r7d a y s ;( n
= 10); Group 5: received infusion of 100 μlG N P so f
size 20 nm for 3 or 7 days (n = 10); Group 6: received
infusion of 100 μlG N P so fs i z e5 0n mf o r3o r7d a y s ;
(n = 10); Control group: received no gold nanoparti-
cles (n = 10).
The rats were maintained on standard laboratory
rodent diet pellets and housed in humidity and tempera-
ture-controlled ventilated cages on a 12 h day/night
cycle. All experiments were conducted in accordance
with the guidelines approved by King Saud University
Local Animal Care and Use Committee.
Fresh portions of the lateral lobes of the liver from
each rat were cut rapidly, fixed in neutral buffered for-
malin (10%), then dehydrated, with grades of ethanol
(70, 80, 90, 95 and 100%). Dehydration was then fol-
lowed by clearing the samples in 2 changes of xylene.
Samples were then impregnated with 2 changes of mol-
ten paraffin wax, then embedded and blocked out. Par-
affin sections (4-5 um) were stained with hematoxylin
and eosin (the conventional histological and stain)
according to Pearse [17].
Stained sections of control and treated rats were
examined for alterations in the hepatocytes for the pre-
sence of inflammatory, fatty change and Kupffer cells
hyperplasia and necrosis.
Results and Discussions
Size and morphology of different gold nanoparticles
The 10 and 20 nm GNPs show spherical shape while
the 50 nm GNPs show hexagonal shape. The mean size
for GNPs was calculated from the images taken by the
transmission electron microscope (TEM): The 10 nm
G N P sw a so fm e a ns i z e9 . 4 5±1 . 3 3n m ,2 0n mG N P s
was of mean size 20.18 ± 1.80 and the 50 nm GNPs was
of mean size 50.73 ± 3.58.
Histological alterations
No mortality occurred in any of the experimental
groups of the present investigation, and no alterations
were observed in the appearance and behavior of GNPs
treated rats in comparison with the control ones.
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histological alterations were detected in the liver of
GNPs treated rats. These alterations were:
1) Hepatocytes exhibited cloudy swelling with pale
cytoplasm and poorly delineated and displaced nuclei
in all GNPs treated rats. This ballooning degeneration
was more prominent with 100 μld o s et h a n5 0μlo n e
and with 10 nm size particles than the larger ones as
shown in Figure 1. This swelling might be exhibited as
a result of disturbances of membranes function that
lead to massive influx of water and Na
+ due to GNPS
effects. Cellular swelling might be accompanied by
leakage of lysosomal hydrolytic enzymes that lead to
cytoplasmic degeneration and macromolecular crowd-
ing [18].
The vacuolated swelling of the cytoplasm of the hepa-
tocytes of the GNPs treated rats might indicate acute
and subacute liver injury induced by these NPs. Variable
nuclei sizes were observed in some hepatocytes. This
change became apparent after 7 days of 50 nm GNPs
administration.
2) The sinusoidal Kupffer cells became prominent and
increased in number due to GNPs exposure. This
change was more prominent at 10 nm GNPs with dose
of 100 μl than 20 nm and 50 nm GNPS and more after
7 days of administration than rats exposed to GNPs for
3 days as shown in Figure 2. Kupffer cells activation
might indicate that GNPs activate the phagocytic activity
of the sinusoidal cells by increasing the number of
Kupffte cells to help in removing the accumulated
GNPs where lysosomes are involved in the intracellular
breakdown into small metabolic products. The produced
Kupffer cells hyperplasia might be correlated with the
amount of injurious to the hepatic tissue induced by
GNPs intoxication and represents a defense mechanism
of detoxification. Kupffer cell hyperplasia is contributed
to hepatic oxidative stress [19].
3) Sporadic spotty well-defined necrosis was noticed in
some hepatocytes of GNPs treated rats as shown in Fig-
ure 3. The insulted cells exhibited highly eosinophilic
amorphous cytoplasm with occasional apoptotic charac-
terization. This alteration was detected in the liver of
rats exposed to 10 nm size particles and to lesser extent
with 20 nm particles but was not seen with those
exposed to 50 nm size particles. Apoptic alteration
might be followed by organelles swelling, specially mito-
chondria, endoplasmic reticulum and rupture of lyso-
somes which might lead to amorphous eosinophilic
cytoplasm as an initial sign in the sequence of hepato-
cytes necrosis before shrinking and dissolution of nuclei
Figure 1 GNPs-treated rat received 50 μl of 10 nm particles for
3 days demonstrating hepatocytes cloudy swelling.
Figure 2 GNPs-treated rat received 50 μl of 10 nm particles for
7 days demonstrating Kupffer cells hyperplasia.
Figure 3 GNPs-treated rat received 50 μl of 10 nm particles for
3 days demonstrating necrotic hepatocytes.
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sure might indicate oxidative stress on these cells by
glutathione depletion.
4) Inflammatory cells infiltration was seen in the por-
tal triads and the perioral zones of GNPs treated rats.
The infiltrate cells were mainly lymphocytes and plasma
cells as shown in Figure 4. This infiltration was more
prominent after 7 days of administration and in rats
received 100 μl than those received 50 μl. The appear-
ance of inflammatory cells in the hepatic tissue may
suggest that GNPs could interact with proteins and
enzymes of the hepatic interstitial tissue interfering with
the antioxidant defense mechanism and leading to reac-
tive oxygen species (ROS) generation which in turn may
imitate an inflammatory response [21].
GNPs were consistently more strongly oxidizing as
evidenced by lipid peroxidation as well as decreased
neutral red retention time (NRRT) and numbers of
thiol-containing proteins evident in electrophoretic
separations. Cadmium may displace iron or copper from
metalloproteins leading to oxidative stress via the Fen-
ton reaction [22].
It has been reported that 5 nm GNPs caused signifi-
cantly greater oxidative stress and cytotoxicity effects
than larger ones [23-25]. The 5 nm GNPs have shown
to catalyze nitric oxide (NO) production from endogen-
ous S-nitroso adducts with thiol groups in blood serum.
NO reacts rapidly with superoxide producing peroxyni-
trite (ONOO-) which can interact with lipids, DNA, and
proteins via direct oxidative reactions or via indirect
radical-mediated damage [24]. ROS production could
result from the proportionately high surface area of
GNPs used in this investigation [26,27].
5) Fatty change was observed in some swelling hepato-
cytes of rats exposed to 100 μlo f1 0n mG N P sa n dt o
lesser extent in the ones exposed to larger particles.
This hepatic liposis was more prominent in rat exposed
to GNPs for 7 days than those received the treatment
for 3 days as shown in Figure 5. Hepatocytes fatty
change might be due to lipid peroxidation that leads to
rough endoplasmic damage and detachment of the cyto-
plasmic lipoprotein which indicate abnormal fat metabo-
lism [22,25-27]. The seen hepatocytes abnormal
retention of lipids in the present investigation induced
by GNPs might indicate toxic injury to liver in the form
of hepatocytes liposis by these particles.
6) The central veins of the hepatic tissue of rats
received 10 and 20 nm GNPs showed disruption of their
intima as shown in Figure 6. Less disruption was
observed in rats exposed to 50 nm GNPs while more
damage was detected after 7 days than 3 days of GNPs
exposure. This alteration might indicate endothelial
damage and vascular stress by GNPs exposure.
None of the above alterations were observed in the
liver of any member of the control group.
Some hepatocytes of rats received 50 nm GNPs
showed nucleoli disappearance. This nuclear damage
was more prominent after 7 days of exposure to GNPs.
Karyorrhexis is a sort of destructive fragmentation of
the nucleus processed by pyknosis and followed by kar-
yolysis. Karyolysis is the complete dissolution of the
chromatin matter of a dying cell.
Binucleation and to lesser extent polynucleation were
observed in GNPs treated rats. Binucleation represents a
consequence of cell injury and is a sort of chromosomes
hyperplasia which is usually seen in regenerating cells.
Figure 4 GNPs-treated rat received 100 μlo f1 0n mp a r t i c l e s
for 3 days demonstrating inflammatory cell infiltration.
Figure 5 GNPs-treated rat received 100 μlo f1 0n mp a r t i c l e s
for 7 days demonstrating hepatic fatty degeneration.
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cytes is shown in Figure 7.
The present study demonstrates that the inflammation
produced in the liver and other tissues/or organs was
more prominent with smaller GNPs ones induced more
affects and related with time exposure of GNPs
Additional experimental investigations related to plasma
and tissues (especially liver) cytokine, histomorphologcal
and ultrastrucural will be performed to cover and under-
stand the toxicity and the potential use of GNPs as thera-
peutic and diagnostic tool. It has been reported that
smaller GNPs caused significantly greater oxidative stress
and cytotoxicity effects than larger ones [23,25].
In present study we have not measured GNPs concen-
tration in urine and feces, but this point will be taken
into our consideration in other new additional
experiments. It has been reported by Lasagna-Reeves et
al., 2010 that administrated NPs were primarily taken
up by liver and spleen in a large quantity and small
amounts distributed in the lung, kidney, heart, and brain
after single administration [26].
Conclusions
Histological alterations induced by GNPs exposure as
shown in the results of the present work could be an indi-
cation of injured hepatocytes due to GNPs toxicity that
became unable to deal with the accumulated residues
resulting from metabolic and structural disturbances caused
by these particles. One might conclude that these altera-
tions are size-dependent with smaller ones induced more
damage with relation with the time exposure of GNPs.
The appearance of hepatocytes cytoplasmic inflamma-
tory cells infiltration, central vein intima disruption,
fatty change and Kupffer cells hyperplasia may suggest
that GNPs interact with proteins and enzymes of the
hepatic tissue interfering with the antioxidant defense
mechanism and leading to reactive oxygen species
(ROS) generation which in turn may induce stress in
the hepatocytes to undergo necrosis.
Additional supplementary histomorphologcal and
ultrastrucural experimental investigations are needed to
cover and understand the toxicity and the potential
therapeutic and diagnostic use.
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